Lisa M. Dunkle
Pediatric Infectious Disease | Infectious Disease
12 Richborough Rd
Madison, CT 06443
Madison, CT 06443
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Real-world effectiveness and safety of protein-based and mRNA COVID-19 vaccines (BEEHIVE trial).
Journal: Vaccine
Published: April 07, 2026
Anti-spike IgG4 and Fc effector responses: The impact of SARS-CoV-2 vaccine platform-specific priming and immune imprinting.
Journal: The Journal of infection
Published: March 17, 2025
Safety and immunogenicity of four sequential doses of NVX-CoV2373 in adults and adolescents: A phase 3, randomized, placebo-controlled trial (PREVENT-19).
Journal: Vaccine
Published: November 07, 2024
Immunogenicity of adjuvanted recombinant SARS-CoV-2 spike protein vaccine after earlier mRNA vaccine doses.
Journal: The Journal of allergy and clinical immunology
Published: November 05, 2024
Analysis of Antibody Markers as Immune Correlates of Risk of Severe COVID-19 in the PREVENT-19 Efficacy Trial of the NVX-CoV2373 Recombinant Protein Vaccine.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 04, 2024
Mechanisms and implications of IgG4 responses to SARS-CoV-2 and other repeatedly administered vaccines.
Journal: The Journal of infection
Published: August 22, 2024
SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials.
Journal: JAMA network open
Published: May 23, 2024
Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials.
Journal: The Journal of infectious diseases
Published: March 21, 2024
Altered IgG4 Antibody Response to Repeated mRNA versus Protein COVID Vaccines.
Journal: medRxiv : the preprint server for health sciences
Published: January 31, 2024
Altered IgG4 antibody response to repeated mRNA versus recombinant protein SARS-CoV-2 vaccines.
Journal: The Journal of infection
Published: January 18, 2024
COVID-19 Vaccine Efficacy in Participants With Weakened Immune Systems From 4 Randomized Controlled Trials.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: December 28, 2023
Last Updated: 09/26/2026